癌症耐药性的标志是癌症耐药性的标志
Muhammad Tufail1, Jia-Ju Hu1, Jie Liang1
1Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, China.
iScience
|June 4, 2024
概括
本综述探讨了关键的抗癌机制,如药物排放和代谢变化. 它强调了未来的策略,包括免疫治疗和人工智能,以获得更好的癌症治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 癌症耐药性对有效治疗构成了重大挑战.
- 机制包括通过ATP结合盒 (ABC) 载体和代谢重编程 (Warburg效应) 的药物流出.
- 癌症干细胞 (CSC) 和非编码RNA (lncRNA,miRNA,circRNA) 在抵抗中起着至关重要的作用.
研究的目的:
- 综合审查癌症耐药性的标志.
- 探索CSC和非编码RNA在治疗失败中的作用.
- 概述未来的方向和治疗策略.
主要方法:
- 文献综述和综合关于癌症耐药性的当前研究.
- 对药物排放,代谢适应和CSCs背后的分子机制的分析.
- 检查非编码RNAs在癌症进展中的调控作用.
主要成果:
- 确定了癌症耐药性的关键标志,包括ABC输送器活性和代谢转变.
- 阐明了CSC和各种非编码RNA对治疗耐药性的贡献.
- 突出了免疫疗法,适应性抵抗策略,人工智能和生物标志物的潜力.
结论:
- 了解癌症耐药性特征对于开发新疗法至关重要.
- 准CSC和非编码RNA为克服抵抗提供了有希望的途径.
- 未来的研究应该专注于个性化医疗,人工智能集成和免疫治疗的进步,以改善患者的治疗结果.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer
48.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.4K


